Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 21, 2023; 29(43): 5800-5803
Published online Nov 21, 2023. doi: 10.3748/wjg.v29.i43.5800
Published online Nov 21, 2023. doi: 10.3748/wjg.v29.i43.5800
Endoscopic submucosal dissection for early gastric cancer: It is time to consider the quality of its outcomes
Gwang Ha Kim, Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan 47241, South Korea
Author contributions: Kim GH wrote and revised the manuscript.
Conflict-of-interest statement: The author reported no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Gwang Ha Kim, MD, PhD, Professor, Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 47241, South Korea. doc0224@pusan.ac.kr
Received: October 7, 2023
Peer-review started: October 7, 2023
First decision: October 16, 2023
Revised: October 25, 2023
Accepted: November 9, 2023
Article in press: November 9, 2023
Published online: November 21, 2023
Peer-review started: October 7, 2023
First decision: October 16, 2023
Revised: October 25, 2023
Accepted: November 9, 2023
Article in press: November 9, 2023
Published online: November 21, 2023
Core Tip
Core Tip: Endoscopic resection, particularly endoscopic submucosal dissection (ESD), is widely used as a standard treatment modality for early gastric cancer (EGC) when the risk of lymph node metastasis is negligible. Recently, the policy of “diagnostic ESD” has been commonly implemented, especially when accurate prediction of the depth of EGC invasion before ESD is impossible; however, it is neither ideal nor scientific. The